Drug interactions
Nivolumab + Siponimod
Severity: Moderate
Nivolumab and Siponimod: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Nivolumab is a PD-1 checkpoint inhibitor that enhances immune activity and can cause immune-related adverse events, while siponimod sequesters lymphocytes. The combined effect is unpredictable, and corticosteroids used for immune toxicity would add to infection risk. Clinical data on the combination are lacking.
What this interaction means in plain words
Nivolumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Nivolumab belongs to Oncology; Siponimod belongs to Central Nervous System.
Why it happens
Pharmacodynamic: opposing immune effects of S1P modulation and PD-1 blockade with unpredictable net result.
What to do
Weigh the need for both agents, and monitor lymphocyte counts and for infection and immune-related adverse events if combined.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Nivolumab and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Siponimod
- Cladribine + Siponimod Contraindicated
- Fingolimod + Siponimod Contraindicated
- Fluconazole + Siponimod Contraindicated
- Influenza virus vaccine quadrivalent intranasal + Siponimod Contraindicated
- Ponesimod + Siponimod Contraindicated
- Siponimod + Thioridazine Contraindicated
Other interactions of Nivolumab
- Nivolumab + Thalidomide Major
- Dexamethasone-tobramycin + Nivolumab Moderate
- Dexamethasone + Nivolumab Moderate
- Efgartigimod / hyaluronidase sc + Nivolumab Moderate
- Efgartigimod alfa + Nivolumab Moderate
- Nivolumab + Ponesimod Moderate
Frequently asked questions
Can I take Nivolumab with Siponimod?
MediHelp rates the interaction as moderate. Nivolumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nivolumab is a PD-1 checkpoint inhibitor that enhances immune activity and can cause immune-related adverse events, while siponimod sequesters lymphocytes. The combined effect is unpredictable, and corticosteroids used for immune toxicity would add to infection risk. Clinical data on the combination are lacking.
How serious is the interaction between Nivolumab and Siponimod?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Weigh the need for both agents, and monitor lymphocyte counts and for infection and immune-related adverse events if combined.
What other medicines interact with Siponimod?
MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
